Back to CS Candriam S.C.A.
AUPH
Showing 0 of 3 quarters
Position history for CSCandriam S.C.A.'s holdings in Aurinia Pharmaceuticals Inc
No. Candriam S.C.A. exited its AUPH (Aurinia Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 130,000 shares worth $852,000. Candriam S.C.A. already held AUPH in its Q1 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.